Parameters | Normal | BPM | EOC |
---|---|---|---|
Sample Size Na (%) | 8 (14.5) | 17 (30.5) | 31 (55) |
Age - Median (min - max) | 61.5 (52–75) | 58.0 (38–81) | 60.0 (48–82) |
BMI - Median (min - max) | 30.7 (24.53–30.98) | 28.00 (19.11–52.00) | 29.3 (19.53–47.11) |
Premenopausal N (%)b | 2 (25) | 7 (41) | 2 (6) |
Postmenopausal N (%)b | 6 (75) | 10 (59) | 29 (94) |
Obesity N (%)b | 3 (38) | 3 (18) | 9 (29) |
Diabetes N (%)b | 3 (38) | 3 (18) | 5 (17) |
Hyperlipidimia N (%)b | 5 (63) | 3 (18) | 13 (41) |
Hypertension N (%)b | 4 (50) | 7 (41) | 7 (22) |
Hypothyroidism N (%)b | 4 (50) | 4 (24) | 4 (13) |
FIGO stage - N (% of EOC) | |||
 Stage I | 8 (25.8) | ||
 Stage II | 4 (12.9) | ||
 Stage III | 17 (54.8) | ||
 Stage IV | 2 (6.5) | ||
Histotype - N (% of EOC) | |||
 Serous | 24 (77.4) | ||
 Mucinous | 4 (12.9) | ||
 Endometrioid | 3 (9.7) |